Tumor Paint (BLZ-100) |
Phase 1 clinical trials for adult skin cancer (completed March 2015), sarcoma, pediatric tumors of the central nervous system (CNS), glioma, and other solid tumors |
NCT02097875, NCT02464332, NCT02462629, NCT02234297, NCT02496065
|
CLR1501 and CLR1502 |
Pre-clinical animal models |
(Swanson, et al., 2015) |
OTL38 |
Phase II clinical trial for FRα-positive ovarian cancer |
NCT02317705 |
cRGD-ZW800-1 |
Pre-clinical animal models |
(Choi, et al., 2013) |
YC-27 |
Pre-clinical animal models |
(Neuman, et al., 2015) |
PSMA-1-IR800 |
Pre-clinical animal models |
(Wang, et al., 2014) |
Fluorocoxib A |
Pre-clinical animal models |
(Ra, et al., 2015; Uddin, et al., 2010) |
BMV109 |
Pre-clinical animal models |
(Segal, et al., 2015; Verdoes, et al., 2013) |
LUM105 |
Phase I clinical trials for sarcomas, soft tissue sarcomas and breast cancer; feasibility clinical trials for breast cancer, GI cancers of the colon, esophagus and pancreas |
NCT01626066, NCT02438358, NCT02584244
|
C-PGC probe |
Pre-clinical animal models |
(Weissleder, et al., 1999) |
MMP-2-sensitive NIRF probe |
Pre-clinical animal models |
(Bremer, et al., 2001) |
Z-Phe-Arg-HMRG |
Pre-clinical animal models |
(Fujii, et al., 2014) |
Lipidated probe 3 |
Pre-clinical animal models |
(Hu, et al., 2014) |
6QCNIR |
Pre-clinical animal models |
(Ofori, et al., 2015) |
RACPP AVB-620 |
Phase I clinical trial for breast cancer |
NCT02391194 |
C-SNAF |
Pre-clinical animal models |
(Ye, et al., 2014) |